Intra-abdominal Infection
📧 Sign up to get email alerts when something new happens for Intra-abdominal Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-10-26FDA Approved: ZERBAXA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for ZERBAXA (ceftolozane/tazobactam) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: the Influence of Prophylactic and Empirical Anti-fungal Treatment in Severe Sepsis Patients With Perforations [Phase 2]
Phase 2 clinical trial evaluating the effect of prophylactic and empirical antifungal therapy in adults with severe sepsis due to intra-abdo…
-
FDA label_change · 2016-08-23FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Amoxicillin and clavulanate potassium submitted by Hikma Pharmaceuticals USA Inc., updating the …
-
FDA approval · 2016-07-26FDA Approved: MOXIFLOXACIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for moxifloxacin hydrochloride (MOXIFLOXACIN) from Fresenius Kabi USA, LLC, indicating a modificatio…
-
FDA approval · 2016-06-29FDA Approved: CEFTRIAXONE SODIUM — Original Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved the Original Application for ceftriaxone sodium from Qilu Pharmaceutical Co., Ltd., a broad-spectrum cephalosporin used to trea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-05-29FDA Approved: METRONIDAZOLE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for Metronidazole, granting approval for a generic metronidazole product. This …
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections
A completed trial assessed whether procalcitonin can guide antibiotic duration in secondary or tertiary peritonitis and intra-abdominal infe…
-
CLINICAL_TRIALS other · 2014-12-18Clinical Trial Update: Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections) [Phase 3]
The Dragon Study, a Phase 3 trial evaluating safety and efficacy for complicated intra-abdominal infections, has completed.
-
FDA approval · 2014-03-05FDA Approved: CIPROFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved the original application for ciprofloxacin (generic) by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections [Phase 4]
A Phase 4 study evaluated the safety and efficacy of doripenem in patients with nosocomial pneumonia, complicated intra-abdominal infections…
-
FDA approval · 2013-06-05FDA Approved: LEVOFLOXACIN — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's Original Application for levofloxacin (generic), granting clearance for a generic version of th…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Autologous Fibrin Glues for Fistulas Closure [Phase 1]
Phase 1 trial evaluating autologous fibrin glue for closure of enterocutaneous fistulas in the setting of intra-abdominal infection; study c…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection [Phase 4]
A Phase 4 study evaluating Zosyn (piperacillin/tazobactam) in hospitalized patients with intra-abdominal infection has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age [Phase 2]
Phase 2 pediatric study evaluating the pharmacokinetics, safety, and tolerability of tigecycline in children aged 8 to 11 years has complete…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Colistin and Rifampicin for MDR-Acinetobacter [Phase 3]
Phase 3 trial evaluating colistin plus rifampicin for multidrug-resistant Acinetobacter infections has completed.
-
FDA approval · 2012-04-09FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original ANDA for vancomycin hydrochloride from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., enabling a g…
-
FDA approval · 2012-03-28FDA Approved: METRONIDAZOLE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for metronidazole filed by Taro Pharmaceuticals U.S.A., Inc. (ANDA077819).
-
FDA approval · 2012-02-17FDA Approved: ERTAPENEM — Supplemental Application (ENDO USA, Inc.)
FDA approved a supplemental application for ertapenem (ertapenem sodium) filed by ENDO USA, Inc. This action updates regulatory status for t…
-
FDA approval · 2012-01-20FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for amoxicillin and clavulanate potassium, authorizing the marketing of thi…
-
CLINICAL_TRIALS trial_result · 2011-11-29Clinical Trial Update: Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections [Phase 1, Phase 2]
Phase 1/2 pharmacokinetic and safety study of meropenem in young infants with intra-abdominal infections has completed with results posted.
-
FDA approval · 2011-10-26FDA Approved: CEFOTETAN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original ANDA for cefotetan from Hikma Pharmaceuticals USA Inc., authorizing a generic cefotetan product.
-
FDA approval · 2011-10-26FDA Approved: MEROPENEM — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's original application for Meropenem as an injectable generic antibiotic.
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam [Phase 4]
Phase 4 trial comparing three days of ertapenem to three days of ampicillin-sulbactam for intra-abdominal infection has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections [Phase 4]
A Phase 4 trial comparing ampicillin/sulbactam to moxifloxacin for complicated intra-abdominal infections has completed.
-
FDA approval · 2011-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium (Hikma Pharmaceuticals USA Inc.), updating the product…